If you would like to participate in a clinical trial of the Australian-Iranian SpikoGen vaccine, you can register via the Spikogen.com website

According to the decision of the National Ethics Committee, people aged 50 and over will not be able to participate in the clinical study of Phase 2 SpikoGen due to being included in the national vaccination program in the next few months.

According to the approved protocol of the clinical study, 4 out of every 4 participants in the study were randomly assigned to receive SpikoGen and 5 to the placebo vaccine.